Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-03-01 @ 2:44 AM
Study NCT ID:
NCT02895360
Status:
COMPLETED
Last Update Posted:
2023-05-10
First Post:
2016-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma
Sponsor:
Basilea Pharmaceutica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-05
First Submit QC Date:
None
Study First Post Date:
2016-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-05
Results First Submit QC Date:
None
Results First Post Date:
2021-10-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-09
Last Update Post Date:
2023-05-10
Last Update Post Date Type:
ACTUAL